Scalar Closed Loop Intraoperative Study
Scalar Closed-Loop STN/GPi DBS Based on Evoked and Spontaneous Potentials (Intraoperative Studies)
2 other identifiers
interventional
5
1 country
1
Brief Summary
The purpose of this study is to measure neural activity during deep brain stimulation (DBS). There are two types of neural activity that we will record from DBS electrodes during this study: DBS local evoked potentials (DLEPs) and spontaneous, local field potentials (LFPs). We will measure the effects of varying stimulation parameters on both the neural activity and changes in motor symptoms -- bradykinesia and tremor -- in subjects with Parkinson's disease (PD). Correlating neural activity characteristics with changes in symptoms will improve our understanding of the mechanisms of action of DBS. This intraoperative study will specifically compare our ability to record neural activity using circuitry developed at Duke for this purpose \[Kent et al, 2015\] to a new, implanted pulse generator (IPG; RC+S) developed by Medtronic. These intraoperative studies will specifically test a preliminary version of the RC+S (that is not designed for implantation), and will lead to a clinical trial assessing the efficacy of the implantable RC+S IPG in PD patients once this device is available and approved for this trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable parkinson-disease
Started Apr 2018
Shorter than P25 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 31, 2017
CompletedFirst Posted
Study publicly available on registry
September 1, 2017
CompletedStudy Start
First participant enrolled
April 5, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 26, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 26, 2019
CompletedResults Posted
Study results publicly available
March 23, 2020
CompletedMarch 23, 2020
March 1, 2020
12 months
August 31, 2017
March 6, 2020
March 6, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants With Recorded Evoked Neural Signals From Deep Brain Stimulation (DBS) Electrodes During DBS for Parkinson's Disease.
Measured by the ability to record neural activity through DBS electrodes using circuitry developed at Duke for this purpose and/or a new implantable pulse generator (IPG; RC+S) developed by Medtronic. These intraoperative studies will specifically test a preliminary version of the RC+S that is not designed for implantation.
End of procedure, approximately 45 minutes
Secondary Outcomes (2)
Number of Participants With Recorded DBS Local Evoked Potentials (DLEPs).
End of procedure, approximately 45 minutes
Number of Participants With Recorded Spontaneous, Local Field Potentials (LFPs).
End of procedure, approximately 45 minutes
Study Arms (1)
Intraoperative Recording During DBS Implant Surgery
OTHERParticipants will be recruited and enrolled from individuals who have Parkinson's disease (PD) and who already are scheduled to undergo the planned deep brain electrode placement for treatment of their movement disorder. Intraoperative recordings of participants' neural signals will be made through the implanted deep brain electrode(s).
Interventions
We will measure the effects of varying stimulation parameters on the neural activity in subjects with Parkinson's disease (PD).
Eligibility Criteria
You may qualify if:
- Parkinson's disease (PD) patients who are scheduled to already undergo the planned deep brain electrode placement for treatment of their movement disorder at Duke University Medical Center.
- Able to understand the study and consent form, and interested in proceeding with research during the invasive brain surgery to receive a DBS system for treatment of PD.
You may not qualify if:
- Inability to execute the motor tasks during the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Dennis Turner
- Organization
- Duke University
Study Officials
- PRINCIPAL INVESTIGATOR
Dennis Turner, M.D.
Duke University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor of Neurosurgery, Neurosurgery
Study Record Dates
First Submitted
August 31, 2017
First Posted
September 1, 2017
Study Start
April 5, 2018
Primary Completion
March 26, 2019
Study Completion
March 26, 2019
Last Updated
March 23, 2020
Results First Posted
March 23, 2020
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share